Log In
BCIQ
Print this Print this
 

Adenosine A2A receptor (ADORA2A)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Adenosine A2A receptor (ADORA2A)

BCIQ
Print ChartPrint this
0 0 1 0 0 0 3 1 1 1 1 1 0 0 0 0 0 1 0 0 0 0 1 0 2 0 0 0 0 0
Phases of DevelopmentPreclinicalPhase IPhase I/IIPhase IIPhase IIIMarketed
Cancer

2

0

0

0

0

0

Cardiovascular

0

0

0

0

1

0

Diagnostic

0

0

0

0

0

1

Neurology

3

1

1

1

1

1

Ophthalmic

0

0

1

0

0

0




 Products Targeting Adenosine A2A receptor (ADORA2A)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

17

$3,558.9M

$1,900.0M

$1,422.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today